List of Tables

Table 1. Peptide CXO Market Size & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Peptide CXO Market Restraints

Table 3. Peptide CXO Market Trends

Table 4. Peptide CXO Industry Policy

Table 5. Global Peptide CXO Revenue by Company, 2020-2025, US$ million

Table 6. Global Peptide CXO Revenue Market Share by Company, 2020-2025

Table 7. Global Peptide CXO Players Market Concentration Ratio (CR3 and HHI)

Table 8. Global Peptide CXO Mergers & Acquisitions, Expansion Plans

Table 9. Global Peptide CXO Manufacturers Product Type

Table 10. Global Headquarters and Manufacturing Base of Peptide CXO Manufacturers

Table 11. China Peptide CXO Revenue by Company, 2020-2025, US$ million

Table 12. China Peptide CXO Revenue Market Share by Company, 2020-2025

Table 13. Global Key Players of Peptide CXO Upstream (Raw Materials)

Table 14. Global Peptide CXO Typical Customers

Table 15. by Type, Global Peptide CXO Revenue & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 16. by Application, Global Peptide CXO Revenue & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 17. By Region, Global Peptide CXO Revenue, 2020 VS 2024 VS 2031, US$ Million

Table 18. By Region, Global Peptide CXO Revenue, 2020-2025, US$ Million

Table 19. By Region, Global Peptide CXO Revenue, 2020-2031, US$ Million

Table 20. By Country, Global Peptide CXO Revenue & CAGR，2020 VS 2024 VS 2031, US$ Million

Table 21. By Country, Global Peptide CXO Revenue, 2020-2025, US$ Million

Table 22. By Country, Global Peptide CXO Revenue, 2026-2031, US$ Million

Table 23. By Country, Global Peptide CXO Revenue Market Share, 2020-2025

Table 24. By Country, Global Peptide CXO Revenue Market Share, 2026-2031

Table 25. Polypeptide Company Information, Head Office, Market Area, and Industry Position

Table 26. Polypeptide Company Profile and Main Business

Table 27. Polypeptide Peptide CXO Models, Specifications, and Application

Table 28. Polypeptide Peptide CXO Revenue and Gross Margin, US$ Million, 2020-2025

Table 29. Polypeptide Recent Developments

Table 30. Bachem Company Information, Head Office, Market Area, and Industry Position

Table 31. Bachem Company Profile and Main Business

Table 32. Bachem Peptide CXO Models, Specifications, and Application

Table 33. Bachem Peptide CXO Revenue and Gross Margin, US$ Million, 2020-2025

Table 34. Bachem Recent Developments

Table 35. LONZA Company Information, Head Office, Market Area, and Industry Position

Table 36. LONZA Company Profile and Main Business

Table 37. LONZA Peptide CXO Models, Specifications, and Application

Table 38. LONZA Peptide CXO Revenue and Gross Margin, US$ Million, 2020-2025

Table 39. LONZA Recent Developments

Table 40. Bicycle Company Information, Head Office, Market Area, and Industry Position

Table 41. Bicycle Company Profile and Main Business

Table 42. Bicycle Peptide CXO Models, Specifications, and Application

Table 43. Bicycle Peptide CXO Revenue and Gross Margin, US$ Million, 2020-2025

Table 44. Bicycle Recent Developments

Table 45. Pepscan Company Information, Head Office, Market Area, and Industry Position

Table 46. Pepscan Company Profile and Main Business

Table 47. Pepscan Peptide CXO Models, Specifications, and Application

Table 48. Pepscan Peptide CXO Revenue and Gross Margin, US$ Million, 2020-2025

Table 49. Pepscan Recent Developments

Table 50. JPT Peptide Company Information, Head Office, Market Area, and Industry Position

Table 51. JPT Peptide Company Profile and Main Business

Table 52. JPT Peptide Peptide CXO Models, Specifications, and Application

Table 53. JPT Peptide Peptide CXO Revenue and Gross Margin, US$ Million, 2020-2025

Table 54. JPT Peptide Recent Developments

Table 55. WuXi AppTec Company Information, Head Office, Market Area, and Industry Position

Table 56. WuXi AppTec Company Profile and Main Business

Table 57. WuXi AppTec Peptide CXO Models, Specifications, and Application

Table 58. WuXi AppTec Peptide CXO Revenue and Gross Margin, US$ Million, 2020-2025

Table 59. WuXi AppTec Recent Developments

Table 60. Asymchem Company Information, Head Office, Market Area, and Industry Position

Table 61. Asymchem Company Profile and Main Business

Table 62. Asymchem Peptide CXO Models, Specifications, and Application

Table 63. Asymchem Peptide CXO Revenue and Gross Margin, US$ Million, 2020-2025

Table 64. Asymchem Recent Developments

Table 65. Jiangsu Sinopep-Allsino Biopharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 66. Jiangsu Sinopep-Allsino Biopharmaceutical Company Profile and Main Business

Table 67. Jiangsu Sinopep-Allsino Biopharmaceutical Peptide CXO Models, Specifications, and Application

Table 68. Jiangsu Sinopep-Allsino Biopharmaceutical Peptide CXO Revenue and Gross Margin, US$ Million, 2020-2025

Table 69. Jiangsu Sinopep-Allsino Biopharmaceutical Recent Developments

Table 70. Chinese Peptide Company Company Information, Head Office, Market Area, and Industry Position

Table 71. Chinese Peptide Company Company Profile and Main Business

Table 72. Chinese Peptide Company Peptide CXO Models, Specifications, and Application

Table 73. Chinese Peptide Company Peptide CXO Revenue and Gross Margin, US$ Million, 2020-2025

Table 74. Chinese Peptide Company Recent Developments

Table 75. AmbioPharm Company Information, Head Office, Market Area, and Industry Position

Table 76. AmbioPharm Company Profile and Main Business

Table 77. AmbioPharm Peptide CXO Models, Specifications, and Application

Table 78. AmbioPharm Peptide CXO Revenue and Gross Margin, US$ Million, 2020-2025

Table 79. AmbioPharm Recent Developments

Table 80. ReaLi Tide Biological Technology Company Information, Head Office, Market Area, and Industry Position

Table 81. ReaLi Tide Biological Technology Company Profile and Main Business

Table 82. ReaLi Tide Biological Technology Peptide CXO Models, Specifications, and Application

Table 83. ReaLi Tide Biological Technology Peptide CXO Revenue and Gross Margin, US$ Million, 2020-2025

Table 84. ReaLi Tide Biological Technology Recent Developments

Table 85. GL Biochem Company Information, Head Office, Market Area, and Industry Position

Table 86. GL Biochem Company Profile and Main Business

Table 87. GL Biochem Peptide CXO Models, Specifications, and Application

Table 88. GL Biochem Peptide CXO Revenue and Gross Margin, US$ Million, 2020-2025

Table 89. GL Biochem Recent Developments

Table 90. Shenzhen JYMed Technology Company Information, Head Office, Market Area, and Industry Position

Table 91. Shenzhen JYMed Technology Company Profile and Main Business

Table 92. Shenzhen JYMed Technology Peptide CXO Models, Specifications, and Application

Table 93. Shenzhen JYMed Technology Peptide CXO Revenue and Gross Margin, US$ Million, 2020-2025

Table 94. Shenzhen JYMed Technology Recent Developments

Table 95. Chengdu Shengnuo Biotechnology Company Information, Head Office, Market Area, and Industry Position

Table 96. Chengdu Shengnuo Biotechnology Company Profile and Main Business

Table 97. Chengdu Shengnuo Biotechnology Peptide CXO Models, Specifications, and Application

Table 98. Chengdu Shengnuo Biotechnology Peptide CXO Revenue and Gross Margin, US$ Million, 2020-2025

Table 99. Chengdu Shengnuo Biotechnology Recent Developments

List of Figures

Figure 1. Peptide CXO Picture

Figure 2. Global Peptide CXO Revenue and Forecast, 2020-2031, US$ Million

Figure 3. China Peptide CXO Revenue and Forecast, 2020-2031, US$ Million

Figure 4. By Revenue, China Peptide CXO Share of Global Market, 2020-2031

Figure 5. Global Peptide CXO Key Participants, Market Share, 2023 VS 2024 VS 2025

Figure 6. Global Peptide CXO Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 7. China Peptide CXO Key Participants, Market Share, 2023 VS 2024 VS 2025

Figure 8. China Peptide CXO Key Participants, Market Share, 2024

Figure 9. China Peptide CXO Revenue, Domestic VS Import Products, Proportion of China Local Companies and Foreign Companies, 2020-2031

Figure 10. Peptide CXO Industry Chain

Figure 11. CRO

Figure 12. CMO/CDMO

Figure 13. by Type, Global Peptide CXO Revenue, 2020-2031, US$ Million

Figure 14. by Type, Global Peptide CXO Revenue Market Share, 2020-2031

Figure 15. Pharmaceutical Companies

Figure 16. Biotech Companies and Research Institutions

Figure 17. by Application, Global Peptide CXO Revenue, 2020-2031, US$ Million

Figure 18. by Application, Global Peptide CXO Revenue Market Share, 2020-2031

Figure 19. By Region, Global Peptide CXO Revenue, 2020-2031, US$ Million

Figure 20. By Region, Global Peptide CXO Revenue Market Share, 2020-2031

Figure 21. North America Peptide CXO Revenue & Forecasts, 2020-2031, US$ Million

Figure 22. By Country, North America Peptide CXO Revenue Market Share, 2024

Figure 23. Europe Peptide CXO Revenue & Forecasts, 2020-2031, US$ Million

Figure 24. By Country, Europe Peptide CXO Revenue Market Share, 2024

Figure 25. Asia Pacific Peptide CXO Revenue & Forecasts, 2020-2031, US$ Million

Figure 26. By Country/Region, Asia Pacific Peptide CXO Revenue Market Share, 2024

Figure 27. South America Peptide CXO Revenue & Forecasts, 2020-2031, US$ Million

Figure 28. By Country, South America Peptide CXO Revenue Market Share, 2024

Figure 29. Middle East & Africa Peptide CXO Revenue & Forecasts, 2020-2031, US$ Million

Figure 30. United States Peptide CXO Revenue, 2020-2031, US$ Million

Figure 31. By Company, United States Peptide CXO Revenue Market Share, 2024

Figure 32. by Type, United States Peptide CXO Revenue Market Share, 2024 VS 2031

Figure 33. by Application, United States Peptide CXO Revenue Market Share, 2024 VS 2031

Figure 34. Europe Peptide CXO Revenue, 2020-2031, US$ Million

Figure 35. By Company, Europe Peptide CXO Revenue Market Share, 2024

Figure 36. by Type, Europe Peptide CXO Revenue Market Share, 2024 VS 2031

Figure 37. by Application, Europe Peptide CXO Revenue Market Share, 2024 VS 2031

Figure 38. China Peptide CXO Revenue, 2020-2031, US$ Million

Figure 39. By Company, China Peptide CXO Revenue Market Share, 2024

Figure 40. by Type, China Peptide CXO Revenue Market Share, 2024 VS 2031

Figure 41. by Application, China Peptide CXO Revenue Market Share, 2024 VS 2031

Figure 42. Japan Peptide CXO Revenue, 2020-2031, US$ Million

Figure 43. By Company, Japan Peptide CXO Revenue Market Share, 2024

Figure 44. by Type, Japan Peptide CXO Revenue Market Share, 2024 VS 2031

Figure 45. by Application, Japan Peptide CXO Revenue Market Share, 2024 VS 2031

Figure 46. South Korea Peptide CXO Revenue, 2020-2031, US$ Million

Figure 47. By Company, South Korea Peptide CXO Revenue Market Share, 2024

Figure 48. by Type, South Korea Peptide CXO Revenue Market Share, 2024 VS 2031

Figure 49. by Application, South Korea Peptide CXO Revenue Market Share, 2024 VS 2031

Figure 50. Southeast Asia Peptide CXO Revenue, 2020-2031, US$ Million

Figure 51. By Company, Southeast Asia Peptide CXO Revenue Market Share, 2024

Figure 52. by Type, Southeast Asia Peptide CXO Revenue Market Share, 2024 VS 2031

Figure 53. by Application, Southeast Asia Peptide CXO Revenue Market Share, 2024 VS 2031

Figure 54. India Peptide CXO Revenue, 2020-2031, US$ Million

Figure 55. By Company, India Peptide CXO Revenue Market Share, 2024

Figure 56. by Type, India Peptide CXO Revenue Market Share, 2024 VS 2031

Figure 57. by Application, India Peptide CXO Revenue Market Share, 2024 VS 2031

Figure 58. Middle East & Africa Peptide CXO Revenue, 2020-2031, US$ Million

Figure 59. By Company, Middle East & Africa Peptide CXO Revenue Market Share, 2024

Figure 60. by Type, Middle East & Africa Peptide CXO Revenue Market Share, 2024 VS 2031

Figure 61. by Application, Middle East & Africa Peptide CXO Revenue Market Share, 2024 VS 2031

Figure 62. Research Methodology

Figure 63. Breakdown of Primary Interviews

Figure 64. Bottom-up Approaches

Figure 65. Top-down Approaches